Literature DB >> 29856892

Structural characterisation of the HT3 motif of the polyhistidine triad protein D from Streptococcus pneumoniae.

Zhenyao Luo1,2,3, Victoria G Pederick4, James C Paton4, Christopher A McDevitt4, Bostjan Kobe1,2,3.   

Abstract

The bacterium Streptococcus pneumoniae (the pneumococcus) is a major human pathogen that requires Zn2+ for its survival and virulence in the host environment. Polyhistidine triad protein D (PhtD) has a known role in pneumococcal Zn2+ homeostasis. However, the mechanistic basis of PhtD function remains unclear, partly due to a lack of structural information. Here, we determined the crystal structure of the fragment PhtD269-339 , containing the third Zn2+ -binding histidine triad (HT) motif of the protein. Analysis of the structure suggests that Zn2+ binding occurs at the surface of the protein and that all five HT motifs in the protein bind Zn2+ and share similar structures. These new structural insights aid in our understanding of how the Pht proteins facilitate pneumococcal Zn2+ acquisition.
© 2018 Federation of European Biochemical Societies.

Entities:  

Keywords:  zzm321990Streptococcus pneumoniaezzm321990; In situ proteolysis; PhtD; X-ray crystallography; polyhistidine triad; zinc acquisition

Mesh:

Substances:

Year:  2018        PMID: 29856892     DOI: 10.1002/1873-3468.13122

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  2 in total

1.  Defining the Role of the Streptococcus agalactiae Sht-Family Proteins in Zinc Acquisition and Complement Evasion.

Authors:  P Moulin; V Rong; A Ribeiro E Silva; V G Pederick; E Camiade; L Mereghetti; C A McDevitt; A Hiron
Journal:  J Bacteriol       Date:  2019-03-26       Impact factor: 3.490

2.  Broadly Reactive Human Monoclonal Antibodies Targeting the Pneumococcal Histidine Triad Protein Protect against Fatal Pneumococcal Infection.

Authors:  Jiachen Huang; Aaron D Gingerich; Fredejah Royer; Amy V Paschall; Alma Pena-Briseno; Fikri Y Avci; Jarrod J Mousa
Journal:  Infect Immun       Date:  2021-04-16       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.